| Biologic Therapy |
0 |
0.98 |
| Microbiome |
0 |
0.99 |
| Fecal Transplant |
0 |
1 |
| Melanoma |
0 |
0.97 |
| Clostridium Difficile Infection |
0 |
0.83 |
| Skin Cancer |
0 |
0.83 |
| Immunotherapy |
0 |
0.37 |
| Cancer |
0 |
0.34 |
| Diet |
0 |
0.17 |
| Medical Life |
0 |
0.17 |
| Texas |
0 |
0.17 |
| Clinician Health and Well-Being |
0 |
0.13 |
| Oregon |
0 |
0.13 |
| Residency |
0 |
0.13 |
| Transplantation |
0 |
0.13 |
| Tumor |
0 |
0.1 |
| Clinical Research |
0 |
0.07 |
| Colonoscopy |
0 |
0.07 |
| Nucleoside Reverse Transcriptase Inhibitors |
0 |
0.07 |
| Antiretroviral Therapy for HIV Infection |
0 |
0.05 |
| Bowel Preparation |
0 |
0.05 |
| HIV Infection |
0 |
0.05 |
| Psoriasis |
0 |
0.05 |
| Antibiotics |
0 |
0.03 |
| Bacteria |
0 |
0.03 |
| Birth |
0 |
0.03 |
| Colitis |
0 |
0.03 |
| Complementary and Alternative Medicine |
0 |
0.03 |
| Dorsum |
0 |
0.03 |
| Drug Development |
0 |
0.03 |
| Food and Drug Administration (FDA) |
0 |
0.03 |
| Grant |
0 |
0.03 |
| Hospital |
0 |
0.03 |
| Immunology |
0 |
0.03 |
| Inflammatory Bowel Disease |
0 |
0.03 |
| Interleukin |
0 |
0.03 |
| Probiotics |
0 |
0.03 |
| T-Lymphocyte |
0 |
0.03 |